$Arcus Biosciences (RCUS.US)$Revenue soared in the past two ...
$Arcus Biosciences(RCUS.US$Revenue soared in the past two years, reaching 380 million in 2021, operating profit reversed losses in 2021 to 54 million, and net profit reached 53 million.
Revenue for the first three quarters of 2022 increased 1.8 times to 80 million, operating profit loss shrank to 210 million, and net profit loss shrunk to 200 million. The annual profit depends entirely on the performance of the fourth quarter, and it is currently difficult to assess its investment value.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
